IFNB1 and multiple sclerosis: These genes are also identified as sensitive biomarkers for IFN-β treatment in multiple sclerosis (Sellebjerg et al., 2008, 2009; Cepok et al., 2009; Hecker et al., 2011, 2013; Malhotra et al., 2011).